Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSeung-Whan Lee, M.D., Ph.D.

About this trial

This study is to compare clinical outcomes between quantitative coronary angiography-guided anatomic complete revascularization and fractional flow reserve-guided physiologic complete revascularization in patients with significant coronary artery disease undergoing percutaneous coronary intervention with drug eluting stent

Eligibility criteria

Qualifiers

Men or women between the ages of 19and older

Typical chest pain or objective evidence of myocardial ischemia suitable for PCI Significant lesions with a diameter stenosis of 50-90% in major epicardial coronary arteries ≥ 2.25 mm in diameter by visual estimation.

The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethical Committee of the respective clinical site.

Disqualifiers

Coronary lesions resulting in the expected inability to perform FFR (ex, severe tortuosity or extreme angulation of the vessels)

Chronic total occlusion

Failed PCI of severe stenotic (diameter stenosis > 90%) or ACS culprit lesions

Previous PCI within 6 months before the index procedure

Trial design

Treatments tested in this trial

  • Percutaneous Coronary Intervention

Treatment groups

2,400 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Seung-Whan Lee, M.D., Ph.D.

Lead sponsor

Asan Medical Center

Sponsor institution

Biotronik Korea Co., Ltd

Collaborator